The second day the entire group of the entire group of GEA Technology Centre – also in Bubendorf for practical demonstrations on: sustained-release particle coating, high sheer mixing, tableting, spheronization and cleaning units. It was followed a tour through the GEA institutions. Afternoon the group discussed case studies taste masking, enteric coating of crystals, the curing of EUDRAGI, fast dissolving tablets, fluidized bed particle coating techniques and PAT.
After the symposium, Dr. Harald Stahl said it was a thoroughly enjoyable two days and very worthwhile. Established brands a lot of good information between the speakers and the participants exchanged,’he said. ‘We all came away having learned a lot. I am particularly grateful for our guest speakers for their valuable contribution and industries for their partnership in this venture Evonik. ‘.
(. Associated PW Caufield 2006 Genetic profiling of the oral microflora with severe early childhood carries Journal of Clinical Microbiology, 45 1: 81-87..This webcast conference for informing parents, teachers and schoolchildren is focused on the most recent neuroscience research, and to to explain and demonstrating the latest evidence-based reading practices all children, adds dyslexia Foundation President Will Baker.
For the year In Dec. 2008 described to quarterly reports on Form 10-Q and other filings with the Securities and Exchange Commission. The Company disclaims any duty and intention to update these forward-looking statements.. Some statements contained herein forward-looking statements, including statements regarding potential partnership with weight management companies Since such statements involve risks and uncertainties comprise, the actual results may expressed or implied expressed or implied by, forward-looking statements. Factors forward-looking statements could cause actual results to from those expressed or tacitly can differ in such forward-looking statements include, but are confined a risk of market acceptance of its products, the risks of the technological and product develop obsolescence, delays in product development, limited to performance the thirty first of commercial partners, which availability of out of adequate asset, the actions of competitors and other competitive risk and that risks and uncertainty in company’s Annual Report on Form 10 – K.